Marché des laxatifs en Asie-Pacifique – Tendances et prévisions du secteur jusqu’en 2030

Analyse et taille du marché des laxatifs en Asie-Pacifique

Le marché des laxatifs en Asie-Pacifique a connu une croissance significative en raison du poids élevé du vieillissement de la population, qui est l'un des principaux facteurs qui ont propulsé la demande du marché. Le niveau élevé de sécurité associé aux produits laxatifs et l'importance croissante accordée à la production de laxatifs à partir de matériaux naturels, synthétiques et biodégradables sont les principaux facteurs qui ont propulsé la demande du marché au cours de la période de prévision.                          

Data Bridge Market Research analyse que le marché des laxatifs en Asie-Pacifique, qui était de 6 914,12 millions USD en 2022, devrait atteindre 12 034,12 millions USD d'ici 2030 et devrait connaître un TCAC de 7,0 % au cours de la période de prévision de 2023 à 2030. Les « laxatifs osmotiques » dominent le segment type du marché des laxatifs en Asie-Pacifique en raison de l'évolution du mode de vie et de l'alimentation. En plus des informations sur les scénarios de marché tels que la valeur marchande, le taux de croissance, la segmentation, la couverture géographique et les principaux acteurs, les rapports de marché organisés par Data Bridge Market Research comprennent également des analyses approfondies d'experts, l'épidémiologie des patients, l'analyse du pipeline, l'analyse des prix et le cadre réglementaire.

Portée et segmentation du marché des laxatifs en Asie-Pacifique

Market Definition

Laxative are the agents which either increase/stimulate bowel movement or loosen stools. They help in accelerate intestinal transit, which speed up the movement of digestive tract to stimulate bowel movement. Itis used for treating constipation, a condition characterized by difficult, infrequent and sometime painful bowel movement. The laxatives are available as Over the Counter (OTC). The four main types of laxative are osmotic laxative, a stimulant laxative, bulk laxative, lubricant, and emollient laxative.

Asia-Pacific Laxative Market Dynamics

Drivers

• Changing Lifestyle and Dietary Habits

The Asia-Pacific region has witnessed a significant shift in lifestyle and dietary habits over the past few decades. As urbanization has accelerated and sedentary lifestyles have become more prevalent, there has been a noticeable increase in gastrointestinal issues, particularly constipation. This shift can be attributed to reduced physical activity, inadequate fiber intake, and a growing preference for processed and convenience foods. These dietary and lifestyle changes have led to a rising incidence of constipation, driving the demand for laxative products in the region.

• Increased Healthcare Awareness

The Asia-Pacific region has seen a notable increase in healthcare awareness and accessibility. This rise in awareness has led to greater recognition and diagnosis of gastrointestinal disorders, including constipation. Patients are now more likely to seek medical advice and opt for pharmaceutical solutions, contributing to the expanding market for laxatives.

• Consumer Preference for OTC Laxatives

Over-the-counter (OTC) laxatives have gained popularity in the Asia-Pacific region due to their convenience and accessibility. Consumers appreciate the ease of purchasing these products without the need for a prescription. Moreover, OTC laxatives are often considered a first-line treatment for mild and occasional constipation. This consumer preference for readily available OTC laxatives has further fueled the growth of the laxative market.

Opportunities

• Rising Health and Wellness Trends

The increasing focus on health and wellness among consumers presents a notable opportunity for laxative manufacturers. Beyond merely providing relief from constipation, manufacturers can position their products as contributors to overall digestive health. This approach aligns with the growing trend of consumers seeking products that promote holistic well-being, creating a potential avenue for market growth.

• Product Innovation in Laxative Formulation

Continuous innovation in laxative formulations offers significant opportunities for market expansion. Manufacturers can invest in research and development to develop gentler and more natural laxatives with fewer side effects. Innovations that enhance tolerability and reduce discomfort associated with laxative use can resonate with consumers seeking effective yet gentle solutions for constipation relief.

Restraints/Challenges

• Stringent Regulatory Oversight

Regulatory bodies in the Asia-Pacific region impose strict regulations on the sale and distribution of pharmaceutical products, including laxatives. These regulations are in place to ensure consumer safety and product efficacy. Manufacturers must adhere to stringent standards and undergo rigorous testing and approvals processes. Compliance with regulatory requirements can lead to increased operational costs and limitations on marketing activities, posing a significant restraint in the market.

• Cultural and Dietary Variations across the Asia-Pacific

Cultural and dietary variations across the Asia-Pacific region require a nuanced and culturally sensitive approach to marketing laxatives. Manufacturers must consider local preferences, traditional remedies, and healthcare practices when promoting their products. Failure to navigate these cultural factors effectively can impact market acceptance and success.

This Asia-Pacific laxative market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the Asia-Pacific laxative market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Development

• In October 2021, Abbott had launched the Duphalac laxative in India. Duphalac Bears in strawberry flavor is a laxative cum food supplement and has met with the FSSAI regulations. It delivers the advantages of a trusted prebiotic and motivates the growth of good bacteria in the digestive system. The product launch would pave an important step in the children’s health improvement. It will result in increased net sales and more product range

Asia-Pacific Laxative Market Analysis and Size

Asia-Pacific laxative market has experienced significant growth due to the high burden of an increase in aging population are the major drivers which propelled the demand of the market. High level safety associated with laxative products and rising emphasis on production of laxatives from natural, synthetic and biodegradable materials are the major drivers which propelled the demand of the market in the forecast period.             

Data Bridge Market Research analyses that the Asia-Pacific laxative market which was USD 6,914.12 million in 2022, is expected to reach USD 12,034.12 million by 2030, and is expected to undergo a CAGR of 7.0% during the forecast period of 2023 to 2030. “Osmotic Laxatives” dominates the type segment of the Asia-Pacific laxative market due to changing lifestyle and dietary. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Asia-Pacific Laxative Market Scope and Segmentation

Market Definition

Laxative are the agents which either increase/stimulate bowel movement or loosen stools. They help in accelerate intestinal transit, which speed up the movement of digestive tract to stimulate bowel movement. Itis used for treating constipation, a condition characterized by difficult, infrequent and sometime painful bowel movement. The laxatives are available as Over the Counter (OTC). The four main types of laxative are osmotic laxative, a stimulant laxative, bulk laxative, lubricant, and emollient laxative.

Asia-Pacific Laxative Market Dynamics

Drivers

• Changing Lifestyle and Dietary Habits

The Asia-Pacific region has witnessed a significant shift in lifestyle and dietary habits over the past few decades. As urbanization has accelerated and sedentary lifestyles have become more prevalent, there has been a noticeable increase in gastrointestinal issues, particularly constipation. This shift can be attributed to reduced physical activity, inadequate fiber intake, and a growing preference for processed and convenience foods. These dietary and lifestyle changes have led to a rising incidence of constipation, driving the demand for laxative products in the region.

• Increased Healthcare Awareness

The Asia-Pacific region has seen a notable increase in healthcare awareness and accessibility. This rise in awareness has led to greater recognition and diagnosis of gastrointestinal disorders, including constipation. Patients are now more likely to seek medical advice and opt for pharmaceutical solutions, contributing to the expanding market for laxatives.

• Consumer Preference for OTC Laxatives

Over-the-counter (OTC) laxatives have gained popularity in the Asia-Pacific region due to their convenience and accessibility. Consumers appreciate the ease of purchasing these products without the need for a prescription. Moreover, OTC laxatives are often considered a first-line treatment for mild and occasional constipation. This consumer preference for readily available OTC laxatives has further fueled the growth of the laxative market.

Opportunities

• Rising Health and Wellness Trends

The increasing focus on health and wellness among consumers presents a notable opportunity for laxative manufacturers. Beyond merely providing relief from constipation, manufacturers can position their products as contributors to overall digestive health. This approach aligns with the growing trend of consumers seeking products that promote holistic well-being, creating a potential avenue for market growth.

• Product Innovation in Laxative Formulation

Continuous innovation in laxative formulations offers significant opportunities for market expansion. Manufacturers can invest in research and development to develop gentler and more natural laxatives with fewer side effects. Innovations that enhance tolerability and reduce discomfort associated with laxative use can resonate with consumers seeking effective yet gentle solutions for constipation relief.

Restraints/Challenges

• Stringent Regulatory Oversight

Regulatory bodies in the Asia-Pacific region impose strict regulations on the sale and distribution of pharmaceutical products, including laxatives. These regulations are in place to ensure consumer safety and product efficacy. Manufacturers must adhere to stringent standards and undergo rigorous testing and approvals processes. Compliance with regulatory requirements can lead to increased operational costs and limitations on marketing activities, posing a significant restraint in the market.

• Cultural and Dietary Variations across the Asia-Pacific

Cultural and dietary variations across the Asia-Pacific region require a nuanced and culturally sensitive approach to marketing laxatives. Manufacturers must consider local preferences, traditional remedies, and healthcare practices when promoting their products. Failure to navigate these cultural factors effectively can impact market acceptance and success.

Ce rapport sur le marché des laxatifs en Asie-Pacifique fournit des détails sur les nouveaux développements récents, les réglementations commerciales, l'analyse des importations et des exportations, l'analyse de la production, l'optimisation de la chaîne de valeur, la part de marché, l'impact des acteurs du marché national et local, les opportunités d'analyse en termes de poches de revenus émergentes, les changements dans la réglementation du marché, l'analyse stratégique de la croissance du marché, la taille du marché, la croissance du marché des catégories, les niches d'application et la domination, les approbations de produits, les lancements de produits, les expansions géographiques, les innovations technologiques sur le marché. Pour obtenir plus d'informations sur le marché des laxatifs en Asie-Pacifique, contactez Data Bridge Market Research pour un briefing d'analyste, notre équipe vous aidera à prendre une décision de marché éclairée pour atteindre la croissance du marché.

Développement récent

• En octobre 2021, Abbott avait lancé le laxatif Duphalac en Inde. Duphalac Bears au goût de fraise est un laxatif et un complément alimentaire conforme aux réglementations de la FSSAI. Il offre les avantages d'un prébiotique de confiance et stimule la croissance de bonnes bactéries dans le système digestif. Le lancement du produit marquerait une étape importante dans l'amélioration de la santé des enfants. Il se traduira par une augmentation des ventes nettes et une gamme de produits plus étendue

Portée du marché des laxatifs en Asie-Pacifique

Le marché des laxatifs en Asie-Pacifique est segmenté en fonction du type, des arômes, de la source, de l'indication, du mode d'achat, de la forme posologique, de la voie d'administration, du type de population, du canal de vente et du canal de distribution. La croissance parmi ces segments vous aidera à analyser les segments de croissance faibles dans les industries et à fournir aux utilisateurs un aperçu précieux du marché et des informations sur le marché pour les aider à prendre des décisions stratégiques pour identifier les principales applications du marché.

Taper

• Laxatifs osmotiques
• Laxatifs stimulants
• Laxatifs et lubrifiants en vrac
• Laxatifs émollients

Saveurs

• Avec des saveurs
• Sans Saveurs

Source

• Naturel
• Synthétique
• Autres

Indication

• Constipation chronique
• Syndrome du côlon irritable avec constipation
• Constipation induite par les opioïdes
• Constipation aiguë
• Autres

Mode d'achat

• Ordonnance
• Sur le comptoir

Forme posologique

• Tablettes
• Gélules
• Poudre
• Liquides et gels
• Suppositoires
• Autres

Voie d'administration

• Orale
• Rectal

Type de population

• Enfants
• Adultes

Canal de vente

• Hôpitaux
• Centres de soins pour personnes âgées
• Soins à domicile
• Pharmacies
• Épiceries/Magasins de produits de santé et de beauté
• Autres

Canal de distribution

• Vente directe
• Grossistes
• Autres

Analyse/perspectives régionales du marché des laxatifs en Asie-Pacifique

Le marché des laxatifs de la région Asie-Pacifique est analysé et des informations sur la taille du marché et les tendances sont fournies par type, saveurs, source, indication, mode d'achat, forme posologique, voie d'administration, type de population, canal de vente et canal de distribution comme référencé ci-dessus.

Les pays couverts dans le rapport sur le marché des laxatifs en Asie-Pacifique sont la Chine, le Japon, l’Inde, la Corée du Sud, Singapour, la Malaisie, l’Australie, la Thaïlande, l’Indonésie, les Philippines et le reste de l’Asie-Pacifique (APAC).

China is leading the growth of the Asia-Pacific region and pharmaceutical/bulk drug intermediates segment is dominating in this country because China is the highest active pharmaceutical ingredient producer globally. India is the fastest growing country due to rising government initiatives for the production of APIs.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as down-stream and up-stream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure Growth Installed Base and New Technology Penetration

The Asia-Pacific Laxative market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for Asia-Pacific Laxative market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the Asia-Pacific Laxative market. The data is available for historic period 2015 to 2020.

Competitive Landscape and Asia-Pacific Laxative Market Share Analysis

The Asia-Pacific Laxative market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the company's focus related to Asia-Pacific laxative market.

Some of the major players operating in the Asia-Pacific laxative market are:

• F. Hoffmann-La Roche Ltd. (Switzerland)
• Mylan N.V. (U.S.)
• Teva Pharmaceutical Industries Ltd. (Ireland)
• Sanofi (France)
• Pfizer Inc. (U.S.)
• GlaxoSmithKline plc (U.K.)
• Novartis AG (Switzerland)
• Merck & Co., Inc. (U.S.)
• AstraZeneca (U.K.)
• Johnson & Johnson Private Limited (U.S.)
• Hikma Pharmaceuticals PLC (U.K.)
• Dr. Reddy's Laboratories Ltd. (India)
• Lupin (India)
• Fresenius Kabi AG (Germany)
• Aurobindo Pharma (India)
• Cipla Inc. (U.S.)
• Bausch Health Companies Inc. (Canada)
• Amneal Pharmaceuticals LLC. (U.S.)
• Apotex Inc. (Canada)
• Eli Lilly and Company (U.S.)

The Asia-Pacific laxative market is segmented on the basis of type, flavors, source, indication, mode of purchase, dosage form, route of administration, population type, sales channel and distribution channel. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

• Osmotic Laxatives
• Stimulant Laxatives
• Bulk Laxatives and Lubricant
• Emollient laxatives

Flavors

• With Flavors
• Without Flavors

Source

• Natural
• Synthetic
• Others

Indication

• Chronic Constipation
• Irritable Bowel Syndrome with Constipation
• Opioid-Induced constipation
• Acute constipation
• Others

Mode of Purchase

• Prescription
• Over-the-Counter

Dosage Form

• Tablets
• Capsules
• Powder
• Liquid and Gels
• Suppositories
• Others

Route of Administration

• Oral
• Rectal

Population Type

• Children
• Adults

Sales Channel

• Hospitals
• Elderly Care Centers
• Home Healthcare
• Pharmacy Stores
• Grocery/Health and Beauty Stores
• Others

Distribution Channel

• Direct Sales
• Wholesalers
• Others

Asia-Pacific Laxative Market Regional Analysis/Insights

The Asia-Pacific laxative market is analysed and market size insights and trends are provided by type, flavors, source, indication, mode of purchase, dosage form, route of administration, population type, sales channel and distribution channel as referenced above.

The countries covered in the Asia-Pacific Laxative market report are China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, and Rest of Asia-Pacific (APAC).

China is leading the growth of the Asia-Pacific region and pharmaceutical/bulk drug intermediates segment is dominating in this country because China is the highest active pharmaceutical ingredient producer globally. India is the fastest growing country due to rising government initiatives for the production of APIs.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as down-stream and up-stream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure Growth Installed Base and New Technology Penetration

Le marché des laxatifs en Asie-Pacifique vous fournit également une analyse détaillée du marché pour chaque pays, la croissance des dépenses de santé pour les équipements en capital, la base installée de différents types de produits pour le marché des laxatifs en Asie-Pacifique, l'impact de la technologie à l'aide de courbes de vie et les changements dans les scénarios réglementaires des soins de santé et leur impact sur le marché des laxatifs en Asie-Pacifique. Les données sont disponibles pour la période historique de 2015 à 2020.

Analyse du paysage concurrentiel et des parts de marché des laxatifs en Asie-Pacifique

Le paysage concurrentiel du marché des laxatifs en Asie-Pacifique fournit des détails par concurrent. Les détails inclus sont la présentation de l'entreprise, les finances de l'entreprise, les revenus générés, le potentiel du marché, les investissements dans la recherche et le développement, les nouvelles initiatives du marché, la présence mondiale, les sites et installations de production, les capacités de production, les forces et les faiblesses de l'entreprise, le lancement du produit, la largeur et l'étendue du produit, la domination des applications. Les points de données ci-dessus fournis ne concernent que l'orientation de l'entreprise vers le marché des laxatifs en Asie-Pacifique.

Certains des principaux acteurs opérant sur le marché des laxatifs en Asie-Pacifique sont :

• F. Hoffmann-La Roche SA (Suisse)
• Mylan NV (États-Unis)
• Teva Pharmaceutical Industries Ltd. (Irlande)
• Sanofi (France)
• Pfizer Inc. (États-Unis)
• GlaxoSmithKline plc (Royaume-Uni)
• Novartis SA (Suisse)
• Merck & Co., Inc. (États-Unis)
• AstraZeneca (Royaume-Uni)
• Johnson & Johnson Private Limited (États-Unis)
• Hikma Pharmaceuticals PLC (Royaume-Uni)
• Dr. Reddy's Laboratories Ltd. (Inde)
• Lupin (Inde)
• Fresenius Kabi AG (Allemagne)
• Aurobindo Pharma (Inde)
• Cipla Inc. (États-Unis)
• Les Compagnies de Santé Bausch Inc. (Canada)
• Amneal Pharmaceuticals LLC. (États-Unis)
• Apotex Inc. (Canada)
• Eli Lilly and Company (États-Unis)

SKU-63762